Shengjie Guo
Papers
4
Total Citations
58
H-Index
3
About
Shengjie Guo is a leading researcher at the intersection of robotic surgery and urologic oncology, with a primary focus on advancing precision in robot-assisted partial nephrectomy (RAPN) and total joint arthroplasty. His work has been instrumental in validating next-generation surgical platforms, most notably through a multicenter randomized controlled noninferiority trial (14 citations) that demonstrated the MP1000 system’s safety and effectiveness compared to the da Vinci Si, a landmark study for surgical robotics in China. Guo has also pioneered the use of three-dimensional reconstruction and surgical planning systems to guide super-selective artery clamping during RAPN, significantly improving ischemia times and specificity while preserving renal function—a critical advance for complex and completely endophytic renal tumors. His state-of-the-art scoping review on robotic-assisted revision arthroplasty (36 citations) has become a key reference for surgeons navigating this challenging field. With over 58 total citations across his most-cited works, Guo’s contributions are shaping the future of minimally invasive, image-guided robotic surgery, offering patients better outcomes through smarter, more targeted interventions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4